{
    "organizations": [],
    "uuid": "1e341657cf527d838a83b0073ac218b88a78f583",
    "author": "",
    "url": "https://www.reuters.com/article/brief-pacira-announces-fda-approval-of-s/brief-pacira-announces-fda-approval-of-supplemental-new-drug-application-for-exparel-as-a-nerve-block-to-produce-regional-analgesia-idUSASC09V6T",
    "ord_in_thread": 0,
    "title": "BRIEF-Pacira Announces FDA Approval Of Supplemental New Drug Application For Exparel As A Nerve Block To Produce Regional Analgesia",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 6 (Reuters) - Pacira Pharmaceuticals Inc:\n* PACIRA ANNOUNCES FDA APPROVAL OF SUPPLEMENTAL NEW DRUG APPLICATION FOR EXPARELÂ® AS A NERVE BLOCK TO PRODUCE REGIONAL ANALGESIA Source text for Eikon: Further company coverage:\n ",
    "published": "2018-04-07T00:42:00.000+03:00",
    "crawled": "2018-04-07T01:03:44.009+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "reuters",
        "pacira",
        "pharmaceutical",
        "inc",
        "pacira",
        "announces",
        "fda",
        "approval",
        "supplemental",
        "new",
        "drug",
        "application",
        "nerve",
        "block",
        "produce",
        "regional",
        "analgesia",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}